Search
Showing 3481 - 3490 of 4030 results
U.S. Attorney, IRS Caution Public to Beware of Potential Scams Related to Economic Impact Payments, COVID-19
SPRINGFIELD, Ill. -- U.S. Attorney John C. Milhiser and Special Agent in Charge of the IRS-Criminal Investigation Chicago Field Office, Kathy A. Enstrom, are reminding the public to beware of possible scams related to economic impact payments made during the COVID-19 pandemic and continuing efforts to defraud the public.
Federal Law Enforcement Encourages the Public to Remain Vigilant to Covid-19 Scams
Maryland U.S. Attorney Robert K. Hur and Special Agent in Charge Kelly R. Jackson of the Internal Revenue Service-Criminal Investigation (IRS-CI), Washington Field Office are again warning taxpayers to be alert to phishing scams relating to COVID-19 economic impact payments that are already being seen. The community must remain on guard against scammers who are striving to steal personal information and money.
Centers for Medicare & Medicaid Services and States Implement Policy Modifications To Ensure That Medicaid Beneficiaries Continue To Receive Prescriptions
Medicaid is a joint Federal-State program that pays for medical assistance for individuals and families with low incomes. All States currently provide coverage for outpatient prescription drugs within their State Medicaid programs. Under section 1135 of the Act, CMS may temporarily waive or modify certain Medicaid requirements to ensure that sufficient health care items and services are available to meet the needs of beneficiaries in times of an emergency. The coronavirus disease 2019 (COVID-19) pandemic highlights the need for States to efficiently and effectively respond to protect the needs...
CDC's Collection and Use of Data on Disparities in COVID-19 Cases and Outcomes
With emerging information on rates of infection and outcomes for the ongoing coronavirus disease 2019 (COVID-19), numerous reports document a disproportionate burden of infection and deaths among communities of color and economically disadvantaged communities. This study will examine data that the Centers for Disease Control and Prevention (CDC) collects and maintains that can be used to assess racial, ethnic, and socioeconomic disparities in COVID-19 cases and outcomes, as well as how CDC uses those data as part of its activities to address the COVID-19 pandemic. We will also examine CDC's...
Geographic Distribution of Provider Relief Funds to Communities Disproportionately Impacted by Adverse COVID-19 Outcomes
As information on rates of infection and outcomes for the ongoing COVID-19 pandemic emerges, numerous reports document racial, ethnic, and socioeconomic disparities in rates of adverse outcomes from COVID-19, including death. This study will review the locations of hospitals that received Provider Relief Funds, with particular attention to hospitals located in communities of color and economically disadvantaged communities that were disproportionately impacted by adverse COVID-19 outcomes (i.e., hospitalization or death).
Medicaid: Expedited Provider Enrollment During COVID-19 Emergency
As a result of the coronavirus disease 2019 (COVID-19) pandemic, Medicaid provider enrollment through State Medicaid agencies has been expedited under the SSA §1135 Authority to Waive Requirements during National Emergencies. Rapid loosening of established provider screening and background check requirements may limit a State's ability to identify providers who are not eligible to participate in Medicaid. Our objective is to determine whether the State agency and providers complied with Federal and State requirements for newly enrolled providers under the national emergency declaration and if...